274 related articles for article (PubMed ID: 26349863)
1. Use of biosynthetic grafts (Omniflow II) for high infection risk haemodialysis vascular access.
Al Shakarchi J; McGrogan D; Yates PJ; Inston N
J Vasc Access; 2016; 17(2):151-4. PubMed ID: 26349863
[TBL] [Abstract][Full Text] [Related]
2. A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access.
Brownie ER; Kensinger CD; Feurer ID; Moore DE; Shaffer D
J Vasc Surg; 2016 Nov; 64(5):1392-1399. PubMed ID: 27444362
[TBL] [Abstract][Full Text] [Related]
3. Cryopreserved venous allograft is an acceptable conduit in patients with current or prior angioaccess graft infection.
Harlander-Locke MP; Lawrence PF; Ali A; Bae E; Kohn J; Abularrage C; Ricci M; Lemmon GW; Peralta S; Hsu J;
J Vasc Surg; 2017 Oct; 66(4):1157-1162. PubMed ID: 28647193
[TBL] [Abstract][Full Text] [Related]
4. Arteriovenous Hybrid Graft with Outflow in the Proximal Axillary Vein.
Murga AG; Chiriano J; Kiang SC; Patel S; Bianchi C; Abou-Zamzam AM; Teruya TH
Ann Vasc Surg; 2017 Jul; 42():39-44. PubMed ID: 28344184
[TBL] [Abstract][Full Text] [Related]
5. Early cannulation grafts for haemodialysis: a systematic review.
Al Shakarchi J; Houston G; Inston N
J Vasc Access; 2015; 16(6):493-7. PubMed ID: 26070093
[TBL] [Abstract][Full Text] [Related]
6. Outcomes comparison of HeRO and lower extremity arteriovenous grafts in patients with long-standing renal failure.
Steerman SN; Wagner J; Higgins JA; Kim C; Mirza A; Pavela J; Panneton JM; Glickman MH
J Vasc Surg; 2013 Mar; 57(3):776-83; discussion 782-3. PubMed ID: 23313186
[TBL] [Abstract][Full Text] [Related]
7. Comparison of FLIXENE™ and standard PTFE arteriovenous graft for early haemodialysis.
Chiang N; Hulme KR; Haggart PC; Vasudevan T
J Vasc Access; 2014; 15(2):116-22. PubMed ID: 24531998
[TBL] [Abstract][Full Text] [Related]
8. Bovine carotid artery xenografts for hemodialysis access.
Pineda DM; Dougherty MJ; Wismer MC; Carroll C; Tyagi S; Troutman DA; Calligaro KD
J Vasc Surg; 2017 Jun; 65(6):1729-1734. PubMed ID: 28366301
[TBL] [Abstract][Full Text] [Related]
9. Single Asian Center Experience Using the Flixene™ Early Cannulation Graft for Hemodialysis Access Creation.
Chang J; Yap HY; Chan SL; Lee QWS; Tan RY; Pang SC; Tan CS; Chong TT; Tang TY
Ann Vasc Surg; 2021 May; 73():171-177. PubMed ID: 33373770
[TBL] [Abstract][Full Text] [Related]
10. The end stage of dialysis access: femoral graft or HeRO vascular access device.
Kudlaty EA; Pan J; Allemang MT; Kendrick DE; Kashyap VS; Wong VL
Ann Vasc Surg; 2015 Jan; 29(1):90-7. PubMed ID: 24952298
[TBL] [Abstract][Full Text] [Related]
11. Upper limb grafts for hemodialysis access.
Shemesh D; Goldin I; Verstandig A; Berelowitz D; Zaghal I; Olsha O
J Vasc Access; 2015; 16 Suppl 9():S34-9. PubMed ID: 25751548
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Geometric Graft Modification on Arteriovenous Graft Patency in Haemodialysis Patients: A Systematic Review and Meta-Analysis.
Sawo P; Moufarrej A; Sloff M; Snoeijs MG; Delhaas T; Tordoir JHM; Mees BME
Eur J Vasc Endovasc Surg; 2020 Oct; 60(4):568-577. PubMed ID: 32807670
[TBL] [Abstract][Full Text] [Related]
14. Immediate-access grafts provide comparable patency to standard grafts, with fewer reinterventions and catheter-related complications.
Wagner JK; Dillavou E; Nag U; Ali AA; Truong S; Chaer R; Hager E; Yuo T; Makaroun M; Avgerinos ED
J Vasc Surg; 2019 Mar; 69(3):883-889. PubMed ID: 30528400
[TBL] [Abstract][Full Text] [Related]
15. Early cannulation prosthetic graft (Acuseal) for arteriovenous access: a useful option to provide a personal vascular access solution.
Aitken EL; Jackson AJ; Kingsmore DB
J Vasc Access; 2014; 15(6):481-5. PubMed ID: 24811599
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of biological grafts for haemodialysis vascular access.
Inston NG
J Vasc Access; 2015; 16 Suppl 9():S82-6. PubMed ID: 25751558
[TBL] [Abstract][Full Text] [Related]
17. Early infection risk with primary versus staged Hemodialysis Reliable Outflow (HeRO) graft implantation.
Griffin AS; Gage SM; Lawson JH; Kim CY
J Vasc Surg; 2017 Jan; 65(1):136-141. PubMed ID: 27687322
[TBL] [Abstract][Full Text] [Related]
18. Removal of infected arteriovenous grafts is morbid and many patients do not receive a new access within 1 year.
Cheng TW; Farber A; Eslami MH; Kalish JA; Jones DW; Rybin D; Siracuse JJ
J Vasc Surg; 2019 Jul; 70(1):193-198. PubMed ID: 30591289
[TBL] [Abstract][Full Text] [Related]
19. Early cannulation of the Flixene™ arteriovenous graft.
Ottaviani N; Deglise S; Brizzi V; Ducasse E; Midy D; Rigothier C; Saucy F; Berard X
J Vasc Access; 2016 Mar; 17 Suppl 1():S75-8. PubMed ID: 26951911
[TBL] [Abstract][Full Text] [Related]
20. Equivalent outcomes with standard and heparin-bonded expanded polytetrafluoroethylene grafts used as conduits for hemodialysis access.
Davies MG; Anaya-Ayala JE; El-Sayed HF
J Vasc Surg; 2016 Sep; 64(3):715-8. PubMed ID: 27183857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
